ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.703,63
-0,12%
S&P 500
5.294,73
-0,04%
Dow Jones
39.910,54
0,10%
Euro vs US Dollar
1,08545
-0,12%
Bitcoin
66.153,39
1,40%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cumberland Pharmaceutical Inc (CPIX)

  7. Cumberland Pharmaceutical Inc (CPIX) News

CPIX

Cumberland Pharmaceutical (CPIX)

Cumberland Pharmaceutical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CPIX
DatumZeitQuelleÜberschriftSymbolFirma
10/05/202422h37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
10/05/202422h37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202423h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202422h05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
30/04/202422h05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
02/04/202422h05PR Newswire (US)NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202423h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202422h05PR Newswire (US)Cumberland Pharmaceuticals Reports Annual 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
27/02/202422h05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/02/202423h27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202323h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202323h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
27/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CPIXCumberland Pharmaceutical Inc
15/12/202322h14Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:CPIXCumberland Pharmaceutical Inc
14/12/202323h09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202323h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202323h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202323h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202323h01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CPIXCumberland Pharmaceutical Inc
17/11/202323h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202323h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202322h05PR Newswire (US)Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202322h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
31/10/202321h05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
17/10/202323h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
13/10/202315h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
10/10/202322h05PR Newswire (US)NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGENASDAQ:CPIXCumberland Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:CPIX

Kürzlich von Ihnen besucht

NASDAQ
NVDA
NVIDIA
NYSE
XOM
Exxon Mobil
CCOM
SILVER
SILVER
NYSE
NKE
Nike
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
TG
BAYN
Bayer
NASDAQ
MSFT
Microsoft
TG
MBG
MercedesBenz
NYSE
JPM
JP Morgan Chase
TG
432
Arbor Metals
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
CCOM
US100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten